Labor, InducedNCT05885087
'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial'
A study testing Foley or balloon catheter in people with Labor, Induced, run by University of Botswana at 1 site in Botswana.
Trial summary
The overall aim of the single arm pilot study was to assess the effectiveness, safety and acceptance of the 'extended balloon catheter' as a method of induction of labour in women receiving care at Princess Marina Hospital(PMH) in Gaborone, Botswana. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Labor, Induced
- What is being tested?
- Foley or balloon catheter
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteBotswana
- Study dates
- 1 Feb 2022to 1 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women 18 years or older without serious morbidity due for labour induction, who give consent to participate.
- Cervix considered too far dilated to retain a single balloon, or single balloon has fallen out while not yet in labour.
- Bishop score of equal or more than 7.
- Nulliparous and multiparous
- Singleton and cephalic
- Gestation >37+0 weeks
- Estimated fetal weight <4kg
Who cannot join
- Previous caesarean delivery
- Very urgent labour induction indications (eg eclampsia, preeclampsia with severe features)
- Ruptured membranes
Trial locations and contacts
1 site in 1 country.
About this study
Official title: 'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial
The overall aim of the single arm pilot study was to assess the effectiveness, safety and acceptance of the 'extended balloon catheter' as a method of induction of labour in women receiving care at Princess Marina Hospital(PMH) in Gaborone, Botswana.
The main questions it aimed to answer were whether 'extended balloon catheter' is an effective method of labour induction, whether it results in increased adverse events for the mother and baby and whether it is associated with increased mother satisfaction.
Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. Delivery interval (time of induction to time of delivery), mode of delivery and Apgar scores were recorded. Adverse maternal and neonatal outcomes were recorded. Participants' satisfaction with the method of induction was assessed using a descriptive scale.
Read the detailed description
Labour induction is indicated when the benefits to the mother and/or foetus of discontinuing the pregnancy outweigh the risks of awaiting spontaneous onset of labour. However, induction of labour is not without risk and the World Health Organisation recommends induction of labour be performed with a clear medical indication and when the expected benefits outweigh potential harms. Established indications for induction of labour include gestational age of 41 completed weeks or more, prelabour rupture of amniotic membranes, hypertensive disorders, maternal medical complications, foetal growth restriction, chorioamnionitis, multiple pregnancy, vaginal bleeding and other complications.
The ideal method for induction should be safe for both the mother and baby, cost effective and not require extensive monitoring. Trans-cervical extra-amniotic Foley catheter placement has been shown to be the safest method of labour induction with fewer maternal and neonatal side effects such as uterine hyperstimulation and changes in foetal heart rate during labour than prostaglandins or oxytocin. It has also been shown that there were no significant differences between caesarean and vaginal deliveries between Foley catheter, prostaglandins and oxytocin, although labour was shown to last longer after induction with Foley catheter than with prostaglandins and oxytocin. These factors can therefore potentially influence the women's preference for either method.
Foley catheter has generally been used for labour induction with an unfavourable cervix and once the cervix is favourable or the Foley method is unsuccessful, prostaglandins or oxytocin with amniotomy are used. In lower and middle income countries like Botswana where patient monitoring during induction of labour and labour is limited and mostly intermittent, mainly due to the limited or lack of monitoring devices to detect uterine hyperstimulation or foetal heart rate changes, a high patient to midwife ratio, and a high HIV prevalence, it may be preferable to avoid amniotomy and risks associated with hyperstimulation with exogenous oxytocin or prostaglandins. There are no randomized trials of Foley catheter induction with a favourable cervix reported in the Cochrane review of mechanical methods of labour induction. To optimize the likelihood of delivery without recourse to amniotomy and oxytocin or prostaglandins, 'extended balloon catheter' has been proposed as a method of continuing induction and augmentation with a Foley catheter rather than switching to other methods.
The purpose of this proposed single arm pilot trial was to test this novel idea of using 'extended balloon catheter' for induction of labour in women with favourable cervix in Botswana, and assess its effectiveness, safety to both the mother and baby as well as patient satisfaction with the procedure. Findings from this study will guide clinical protocols on how to utilize the safest available option for optimal maternal and neonatal outcomes as well as offer options and evidence for counselling women for whom prostaglandins or oxytocin are contraindicated or for use with caution in Botswana and elsewhere.
- Conditions
- Labor, Induced
- Being tested
- Foley or balloon catheter
- Keywords
- foley/balloon catheter, labor induction, favorable cervix
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Foley or balloon catheterDevice
Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied.
| Study group | Role | What they receive |
|---|---|---|
| Foley/Balloon catheter arm | Experimental | Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. Receives: Device: Foley or balloon catheter |
What is being measured
The primary outcome is the main question the study is designed to answer.
Successful labor induction
Successful labor induction defined as vaginal birth within 60 hours.
Measured: Enrolment until 60 hours
Secondary outcomes (2)
Adverse event
Any adverse maternal and fetal outcomes in participants
Measured: Enrolment until discharge from hospital, or up to 2 weeks
Acceptability
Satisfaction with the procedure as defined by postpartum questionnaire
Measured: Enrolment until discharge from hospital, or up to 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jun 2023
- Study start1 Feb 2022
- Primary completion1 Aug 2022
- Study completion1 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Labor, InducedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- single group prospective trial
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Botswana
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lorato Matshitsa, University of Botswana
- Investigators
- JUSTUS HOFMEYR, DSc, Study director, University of Botswana
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05885087
- Sponsor's protocol ID
- UBR/RES/IRB/BIO/GRAD/145
- Status last verified
- May 2023
- First submitted
- 7 May 2023
- Last updated
- 1 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Study protocol, consent form and data collection tool.
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- 'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial
- ClinicalTrials.gov ID
- NCT05885087
- Acronym / sponsor ID
- UBR/RES/IRB/BIO/GRAD/145
- Conditions
- Labor, Induced
- Keywords
- foley/balloon catheter, labor induction, favorable cervix
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of BotswanaUniversity, hospital or other
- Study start
- 1 Feb 2022 (actual)
- Primary completion
- 1 Aug 2022 (actual)
- Study completion
- 1 Sep 2022 (actual)
- First posted
- 1 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The overall aim of the single arm pilot study was to assess the effectiveness, safety and acceptance of the 'extended balloon catheter' as a method of induction of labour in women receiving care at Princess Marina Hospital(PMH) in Gaborone, Botswana.
The main questions it aimed to answer were whether 'extended balloon catheter' is an effective method of labour induction, whether it results in increased adverse events for the mother and baby and whether it is associated with increased mother satisfaction.
Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. Delivery interval (time of induction to time of delivery), mode of delivery and Apgar scores were recorded. Adverse maternal and neonatal outcomes were recorded. Participants' satisfaction with the method of induction was assessed using a descriptive scale.
Detailed description
Labour induction is indicated when the benefits to the mother and/or foetus of discontinuing the pregnancy outweigh the risks of awaiting spontaneous onset of labour. However, induction of labour is not without risk and the World Health Organisation recommends induction of labour be performed with a clear medical indication and when the expected benefits outweigh potential harms. Established indications for induction of labour include gestational age of 41 completed weeks or more, prelabour rupture of amniotic membranes, hypertensive disorders, maternal medical complications, foetal growth restriction, chorioamnionitis, multiple pregnancy, vaginal bleeding and other complications.
The ideal method for induction should be safe for both the mother and baby, cost effective and not require extensive monitoring. Trans-cervical extra-amniotic Foley catheter placement has been shown to be the safest method of labour induction with fewer maternal and neonatal side effects such as uterine hyperstimulation and changes in foetal heart rate during labour than prostaglandins or oxytocin. It has also been shown that there were no significant differences between caesarean and vaginal deliveries between Foley catheter, prostaglandins and oxytocin, although labour was shown to last longer after induction with Foley catheter than with prostaglandins and oxytocin. These factors can therefore potentially influence the women's preference for either method.
Foley catheter has generally been used for labour induction with an unfavourable cervix and once the cervix is favourable or the Foley method is unsuccessful, prostaglandins or oxytocin with amniotomy are used. In lower and middle income countries like Botswana where patient monitoring during induction of labour and labour is limited and mostly intermittent, mainly due to the limited or lack of monitoring devices to detect uterine hyperstimulation or foetal heart rate changes, a high patient to midwife ratio, and a high HIV prevalence, it may be preferable to avoid amniotomy and risks associated with hyperstimulation with exogenous oxytocin or prostaglandins. There are no randomized trials of Foley catheter induction with a favourable cervix reported in the Cochrane review of mechanical methods of labour induction. To optimize the likelihood of delivery without recourse to amniotomy and oxytocin or prostaglandins, 'extended balloon catheter' has been proposed as a method of continuing induction and augmentation with a Foley catheter rather than switching to other methods.
The purpose of this proposed single arm pilot trial was to test this novel idea of using 'extended balloon catheter' for induction of labour in women with favourable cervix in Botswana, and assess its effectiveness, safety to both the mother and baby as well as patient satisfaction with the procedure. Findings from this study will guide clinical protocols on how to utilize the safest available option for optimal maternal and neonatal outcomes as well as offer options and evidence for counselling women for whom prostaglandins or oxytocin are contraindicated or for use with caution in Botswana and elsewhere.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- single group prospective trial
| Arm | Type | Receives |
|---|---|---|
| Foley/Balloon catheter arm | Experimental | Device: Foley or balloon catheterParticipants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Women 18 years or older without serious morbidity due for labour induction, who give consent to participate.
- Cervix considered too far dilated to retain a single balloon, or single balloon has fallen out while not yet in labour.
- Bishop score of equal or more than 7.
- Nulliparous and multiparous
- Singleton and cephalic
Key exclusion criteria (3 listed)
- Previous caesarean delivery
- Very urgent labour induction indications (eg eclampsia, preeclampsia with severe features)
- Ruptured membranes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Foley or balloon catheterThree Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. | Device | Foley/Balloon catheter arm |
Primary outcome
Successful labor induction
Time frame: Enrolment until 60 hours
Successful labor induction defined as vaginal birth within 60 hours.
2 secondary outcomes
Adverse event
Time frame: Enrolment until discharge from hospital, or up to 2 weeks
Acceptability
Time frame: Enrolment until discharge from hospital, or up to 2 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2023.
- Individual participant dataSharing planned: Yes. Study protocol, consent form and data collection tool.
Related trials for Labor, Induced
Recruiting
The Ophthalmic Artery Doppler Evaluation Prior to Labor Induction and Adverse Intrapartum Fetal Outcomes
Ophthalmic Artery, Labor and Delivery
Not yet recruiting
Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover Trial
Apnea of Prematurity, Intermittent Hypoxemia
RecruitingPhase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Ulcerative Colitis
RecruitingPhase 4
Impact of Higher Zinc Supplementation on Neonatal Weight Velocity
Extreme Prematurity,Extremely Low Birthweight, BPD - Bronchopulmonary Dysplasia
Active, not recruiting
Calcium Carbonate on Labor Induction
Pregnancy, Uterine Contraction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
JUSTUS HOFMEYR, DSc study director
University of Botswana
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Foley or balloon catheter in people with Labor, Induced, run by University of Botswana at 1 site in Botswana.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Botswana. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Successful labor induction (time frame: Enrolment until 60 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2023.